Numinus to Participate in Upcoming Research & Industry Conferences
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental healthcare company advancing innovative treatments and...
Stay updated with breaking news from Trials Looking. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental healthcare company advancing innovative treatments and...
NIH Pauses Anticoagulant Trial For Critically Ill COVID-19 Patients Therapeutic anticoagulation trials is looking at which blood thinners are best to use to treat COVID-caused venous thrombosis embolism (VTE) Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al. December 23, 2020 — Three clinical trial platforms working t...